Raven, from the article:
The agency had moved to the Idu factory of the drug manufacturer to investigate allegations of impropriety against the company. Abu Jimoh, public relations manager of NAFDAC, who confirmed the development, told the magazine, Monday, November 26, that Xechem would be allowed to resume production after it has satisfied NAFDAC’s requirements.